Autoimmune polyendocrine syndrome diagnostic study of choice: Difference between revisions
Akshun Kalia (talk | contribs) |
Akshun Kalia (talk | contribs) |
||
| Line 18: | Line 18: | ||
There are no established criteria for the diagnosis of [disease name]. | There are no established criteria for the diagnosis of [disease name]. | ||
==Diagnostic Criteria== | ==Diagnostic Criteria== | ||
*The diagnosis of | *The diagnosis of autoimmune polyendocrine syndrome(APS) type 1 is made when at least 2 of the following 3 conditions are present: | ||
** | **Mucocutaneous candidiasis | ||
** | **Hypoparathyroidism | ||
** | **Adrenal insufficiency | ||
*The diagnosis of [disease name] is based on the [criteria name] criteria, which include | *The diagnosis of [disease name] is based on the [criteria name] criteria, which include | ||
**[criterion 1] | **[criterion 1] | ||
Revision as of 18:59, 25 September 2017
|
Autoimmune polyendocrine syndrome Microchapters |
|
Differentiating Autoimmune polyendocrine syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Autoimmune polyendocrine syndrome diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Autoimmune polyendocrine syndrome diagnostic study of choice |
|
FDA on Autoimmune polyendocrine syndrome diagnostic study of choice |
|
CDC on Autoimmune polyendocrine syndrome diagnostic study of choice |
|
Autoimmune polyendocrine syndrome diagnostic study of choice in the news |
|
Blogs on Autoimmune polyendocrine syndrome diagnostic study of choice |
|
Directions to Hospitals Treating Autoimmune polyendocrine syndrome |
|
Risk calculators and risk factors for Autoimmune polyendocrine syndrome diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].
OR
The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].
OR
The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].
OR
There are no established criteria for the diagnosis of [disease name].
Diagnostic Criteria
- The diagnosis of autoimmune polyendocrine syndrome(APS) type 1 is made when at least 2 of the following 3 conditions are present:
- Mucocutaneous candidiasis
- Hypoparathyroidism
- Adrenal insufficiency
- The diagnosis of [disease name] is based on the [criteria name] criteria, which include
- [criterion 1]
- [criterion 2]
- [criterion 3]
- The diagnosis of [disease name] is based on the [definition name] definition, which includes
- [criterion 1]
- [criterion 2]
- [criterion 3]
OR There are no established criteria for the diagnosis of APS type 1. However, the diagnosis of APS-1 is usually made with two or three of the following conditions:[1][2]
- Mucocutaneous candidiasis,
- Hypoparathyroidism and/or adrenal insufficiency
- Autoantibodies against CYP450c21, 21 hydroxylase.
An important point worth mentioning in APS type 1, is that the symptoms develop over the course of years and decades. Thus in patients having autoimmune disorders of two more organs suggestive of APS type 1 should undergo regular screening to identify other associated conditions. Suspected patients can also be tested for AIRE gene mutation.
References
- ↑ Husebye ES, Perheentupa J, Rautemaa R, Kämpe O (2009). "Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I". J. Intern. Med. 265 (5): 514–29. doi:10.1111/j.1365-2796.2009.02090.x. PMID 19382991.
- ↑ Perheentupa J (2002). "APS-I/APECED: the clinical disease and therapy". Endocrinol. Metab. Clin. North Am. 31 (2): 295–320, vi. PMID 12092452.